Akèy › Amfizèm
Etid klinik pou Amfizèm ap rekrite nan Etazini
19 etid pou Amfizèm ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Boston, MA8 etid
- Chicago, IL7 etid
- Pittsburgh, PA4 etid
- Orlando, FL4 etid
- Birmingham, AL4 etid
- Philadelphia, PA4 etid
- Houston, TX4 etid
- New York City, NY3 etid
- Milwaukee, WI3 etid
- Cleveland, OH3 etid
- Phoenix, AZ3 etid
- Dallas, TX3 etid
Pa eta
- Alabama4 etid
- Arizona4 etid
- Colorado3 etid
- Florid6 etid
- Illinois8 etid
- Kalifòni8 etid
- Massachusetts9 etid
- Michigan3 etid
- New York4 etid
- Ohio3 etid
- Pennsylvania7 etid
- South Carolina3 etid
- Texas6 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Gene Therapy for Alpha 1- Antitrypsin Deficiency
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT06996756A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Ap rekriteFaz 2
Laj 40 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07759245An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Sep 17, 2026 · NCT06035120Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
Ap rekrite
Laj 40 a 75 · Tout sèks · Mizajou Aug 28, 2026 · NCT05257681A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 11, 2026 · NCT07555483STRIVE Post-Market Registry Study
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Jun 3, 2026 · NCT07119229Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Ap rekrite
Laj 40 a 84 · Tout sèks · Mizajou Apr 24, 2026 · NCT06891755Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
Ap rekrite
Laj 40 a 75 · Tout sèks · Mizajou Apr 13, 2026 · NCT04801108PiMZ Longitudinal Cohort (PiMZ Logic)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT06505603Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Ap rekriteFaz 1/2
Laj 18 a 60 · Tout sèks · Mizajou Jan 13, 2026 · NCT03500731Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT01776398Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Oct 30, 2025 · NCT07059637Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 24, 2025 · NCT01177618Emphysema Research Registry and Biosample Repository
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 ak plis · Tout sèks · Mizajou Sep 25, 2025 · NCT00307281COPD Resources, Education, and Activity Designed for You Study
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Sep 22, 2025 · NCT07125053Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06122077Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Oct 27, 2023 · NCT03263130COPD Patient-Powered Research Network
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 10, 2022 · NCT02803242Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.